MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Association Between Antiepileptic Drugs and Subsequent Parkinson’s Disease in East London

    Q. Zhang, J. Bestwick, R. Dobson, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the association between antiepileptic drugs (AEDs) prescription and subsequent Parkinson’s disease (PD). Background: Recent observational studies have highlighted an association between epilepsy…
  • 2023 International Congress

    Reaching kinematics in patients with Spinocerebellar Ataxia Type 12 using a markerless motion tracking system

    ABB. Bayen, SC. Choudhury, SM. Majumdar, PB. Basu, MRB. Baker, SNB. Baker, H. Kumar (KOLKATA, India)

    Objective: In the current study, we compared the kinematics of planar reaching movements between patients with Spinocerebellar Ataxia Type 12 (SCA12) and healthy control using…
  • 2023 International Congress

    Blood NfL can track progression in multiple system atrophy

    V. Chelban, A. Perez-Soriano, C. Wilke, A. Foubert-Samier, N. Vijiaratnam, T. Guo, E. Jabbari, K. Senkevich, B. Laurens, P. Péran, O. Rascol, L. Schöls, C. Kobylecki, M. Hu, J. Rowe, T. Foltynie, N. Wood, A. Heslegrave, H. Zetterberg, M. Bocchetta, J. Rohrer, M. Marti, M. Synofzik, H. Morris, W. Meissner, H. Houlden (London, United Kingdom)

    Objective: To validate the role of NfL for disease progression, severity and subject trial selection in MSA. Neurofilament light (NfL) was explored in this regard though…
  • 2023 International Congress

    Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

    A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

    Objective: To investigate the neuroprotective effects of novel arylpiperazine compounds as measured by viability of SH-SY5Y cells in vitro. Background: Parkinson’s disease (PD) is a…
  • 2023 International Congress

    Istradefylline therapy for PD plus oromandibular dystonia

    NAO. Kanzato, SAT. Mochizuki (Haearu-cho, Okinawa, Japan)

    Objective: To clarify the dopaminergic system link between parkinson's disease (PD) and oromadibular dystonias (OMDy) co-occur, and the effect of istradefylline (IST) therapy. Background: OMDy are…
  • 2023 International Congress

    Risk Factors for Stimulation-Induced Bradykinesia in Dystonia Patients Treated with Deep Brain Stimulation: A Retrospective Analysis.

    F. Lange, B. Karandasch, P. Mahlknecht, J. Kraus, A. Kühn, G. Deuschl, J. Volkmann, M. Reich (Würzburg, Germany)

    Objective: Identification of risk factors for stimulation-induced bradykinesia in GPi-DBS Background: Deep brain stimulation (DBS) is an effective treatment for dystonia, but some patients may…
  • 2023 International Congress

    Effectiveness of use of Pictographs on Levodopa packaging to ensure awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease.

    M. Matta, N. Sawal (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. This study aimed to evaluate the effect pictographs on Levodopa packaging Fig 1 on increasing patient…
  • 2023 International Congress

    Addition contact with 10 Hz stimulation in the STN may improve stimulation-induced cognitive disturbances

    A. Boogers, M. Cohn, M. Bernstein, A. Fasano (Toronto, Canada)

    Objective: This case report demonstrates improvement of cognition by adding low-frequency stimulation in the ventral subthalamic nucleus (STN). Background: Deep brain stimulation (DBS) targeting the…
  • 2023 International Congress

    Longitudinal association of mild behavioral impairment with cognitive decline in Parkinson’s disease

    G. Pinilla-Monsalve, M. Kibreab, N. Maarouf, I. Kathol, Z. Ismail, O. Monchi (Montréal, Canada)

    Objective: To analyze the cross-sectional and longitudinal association between mild behavioral impairment and cognitive impairment in Parkinson’s disease. Background: Cognitive impairment and neuropsychiatric symptoms (NPS)…
  • 2023 International Congress

    ParkProReakt Study Protocol – A randomized controlled trial to evaluate a proactive approach to health care in Parkinson’s disease

    M. van Munster, J. Stümpel, N. Altschuck, L. Kerkemeyer, I. Wellach, D. Becker, M. Geraedts, D. Pedrosa (Marburg, Germany)

    Objective: To implement and evaluate a novel care model for people with Parkinson’s Disease (PD), based on the following principles: proactive, person-centered, and digital (cf.…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley